Volume 14 - Issue 11 - November 2017
VASCULAR DISEASE MANAGEMENT 2017;14(11):E230

Dr Walker comments on drug-coated balloon technology and how a decision by CMS may cause their utilization to fall. | Read More

Sandra Vicente, MD, PhD; Miguel Gutierrez, MD; Fernando Criado, MD; Jesús Alfayate, MD;
Susana Cancer, MD; Myriam Pereira, MD; Cristina Garmendia, MD; Luis De Benito, MD, PhD.

Department of Angiology, Vascular and Endovascular Surgery, Alcorcon Fundation Hospital, Alcorcon, Madrid.

VASCULAR DISEASE MANAGEMENT 2017;14(11):E235-E237

Ureteroarterial fistula represents an infrequent but potentially fatal cause of hematuria. The authors present the clinical course of an ureteroiliac arterial fistula in a patient who was managed by iliac stenting for 2 years and had an infection… | Read More

Priyadarshini Arunakumar, DM; Anoop Ayyappan, MD
Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, India

VASCULAR DISEASE MANAGEMENT 2017;14(11):E238-E239

An 11-year old girl presented with history of recurrent pneumonia since early childhood and symptoms suggestive of gastroesophageal reflux. She was sent for cardiac evaluation as a part of a workup for persistent respiratory symptoms.  | Read More

Jenny Plácido-Disla, MD; Bora Toklu, MD; Ramita N. Gowda; Ramesh M. Gowda, MD

1Mount Sinai Heart, Mount Sinai Beth Israel, New York, New York; 2College of New Jersey, Ewing, New Jersey

VASCULAR DISEASE MANAGEMENT 2017;14(11):E231-E234

The authors discuss indications for revascularization in chronic venous insufficiency, complications associated with venous stent placement, and the risk factors for venous stent migration. | Read More